뉴스
- Exclusive: Over 3,000 Hong Kong investors enter Korean market as city ran... The momentum continued this year, with the index surging another 110... the Kospi 200 and the Kospi 200 Tapping Hong Kong’s wealth Korean...
- The Hidden Cost of Farmed Seafood on South Korean Tables s Seafood Problems Start Elsewhere In May 2025, the CEO of the Aquaculture Stewardship Council met with South Korean government officials to tout the promising future of the...
- KM Pharmaceutical Surges Despite Delisting; SK Biopharm Falls on FDA Hold [K-Bio Pulse] Korean pharmaceutical and biotech stocks showed mixed performances on Sept. 11, with KM Pharmaceutical
- OpenAI's Stargate project in Korea stuck at starting gate as Samsung, SK ... Last October, OpenAI CEO Sam Altman brought plans for a Korean leg of Stargate — an AI... broader OpenAI partnership with Samsung and SK announced last October — aimed at building two data...
- Twosome Place Makes Its Debut in America with First Store in Alexandria Top', 'Korean Apple Cinnamon Tea', 'Green Plum Refresher', and 'Misugaru Frappe'. The store will also serve light meals, including 'K-Toast' made with bulgogi and egg, and 'Beef Bulgogi
- U.S.-N. Korea talks key to breaking stalemate: Seoul official South and North Korea remain technically at war, as the 1950-53 Korean War ended with an armistice. Scaling back the joint Ulchi Freedom Shield exercise, along with Trump's vagueness on whether...
- Nvidia Earnings, Rate Calls to Test Korean Stocks South Korean stocks face a series of major market events this week, with Nvidia's earnings, the...
- JW Pharma Jumps 15%, OliX Sinks 14% on Overhang Concerns[K-Bio Pulse] South Korean pharmaceutical and biotech stocks broadly traded lower, with JW Pharmaceutical and OliX
- Lee Kang-in marks Spain return with 1st goal for Atletico Madrid football-player Lee Kang-in marks Spain return with 1st goal for Atletico Madrid By Yoo Jee-ho SEOUL, Aug. 20 (Yonhap) -- South Korean midfielder Lee Kang-in celebrated his return to Spain by...
- Biotech Stocks Rally with Market Rebound; Orum Therapeutics Jumps 18% [K-Bio Pulse] On July 31, South Korean pharmaceutical and biotech stocks broadly advanced as domestic equities rebounded , with bargain hunting returning to beaten-down growth and biotech names.
1 페이지
다음 →